Insider Holders & Insider Ownership - NeuroBo Pharmaceuticals Inc. (NRBO)

List of insiders holdings for NeuroBo Pharmaceuticals Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
DONG-A ST CO. LTD
10% Owner
2024-09-20 16:20:1611,709,117
0
11,709,117Form 4
E&Investment Inc.
E&Healthcare Investment Fund II
10% Owner
2022-08-05 16:25:366,113,798
0
6,113,798Form 13D
E&Investment Inc.
E&Healthcare Investment Fund II
E&Healthcare Investment Fund No.7
10% Owner
2022-08-05 16:25:366,113,798
0
6,113,798Form 13D
GOLDMAN SACHS GROUP INC
GOLDMAN SACHS & CO. LLC
10% Owner
2022-11-22 16:46:000
1,220,502
1,220,502Form 3
Bakshi Akash
SVP and COO
2021-01-05 16:09:0229,013
884,072
913,085Form 4
Sooch Mina
President & CEO
2017-02-14 16:37:38813,383
0
813,383Form 13G
Lowenschuss David
Chief Legal Off. & Secretary
2017-02-14 14:10:25806,247
0
806,247Form 13G
Price Ben Gil
CEO and President
2021-11-04 16:57:38616,666
0
616,666Form 4
Versavel Mark
Chief Medical Officer
2020-01-02 21:54:16342,930
0
342,930Form 4
Kim Na Yeon
Director
10% Owner
2023-07-28 06:08:20101,459
200,554
302,013Form 4
Oniciu Carmen Daniela
Vice President
2016-08-12 12:56:23152,646
0
152,646Form 4
SASSINE ANDY
Director
2019-07-26 16:38:02151,264
0
151,264Form 4
Golden Lee Scott
Chief Medical Officer
2018-01-30 16:27:49148,000
0
148,000Form 4
Reno Seth
Chief Commercial Officer
2019-07-26 16:16:56118,286
0
118,286Form 4
LICHTINGER PEDRO
Director
2019-07-26 16:30:5974,833
0
74,833Form 4
Kim Hyung Heon
CEO & President
2024-08-13 16:01:1066,666
0
66,666Form 4
Gullans Steven R. Ph.D.
Director
2020-01-15 19:11:2060,000
0
60,000Form 4
Jeong Tae Heum
Director
2020-01-15 19:12:4860,000
0
60,000Form 4
Oh Jeong Gyun
Director
10% Owner
2020-01-15 19:15:3360,000
0
60,000Form 4
Swirsky Douglas J
Director
2020-09-03 18:48:5760,000
0
60,000Form 4
Bisgaier Charles PhD
Chief Scientific Off. & Chair
10% Owner
2020-01-10 08:28:4058,012
0
58,012Form 13D
MATHIESEN JEFFREY S
Chief Financial Officer
2018-01-30 16:20:4148,000
0
48,000Form 4
Woodworth Marshall H
Chief Financial Officer
2024-03-04 21:20:5633,496
0
33,496Form 4
KOUSKY KENNETH W
Director
2019-07-26 16:24:4026,935
0
26,935Form 4
Kang Richard
Director
2022-06-10 17:25:2420,000
0
20,000Form 4
STRICKLAND D GORDON
Director
2024-06-07 19:24:4417,552
0
17,552Form 4
KOVEN ANDREW I
Director
2024-06-07 19:25:3217,552
0
17,552Form 4
GROVES JASON L
Director
2024-06-07 19:26:0817,552
0
17,552Form 4
Salsbury Michael
Director
2024-06-07 19:26:3717,552
0
17,552Form 4
Hawryluk P. Kent
Director
2018-01-30 16:44:3010,800
0
10,800Form 4
Glickman Mark A
Director
2024-06-07 19:25:099,740
0
9,740Form 4
Tursi James Patrick
Director
2024-06-07 19:24:169,072
0
9,072Form 4
Hooker Joseph
Interim CEO and President
2023-01-18 16:15:440
0
0Form 3
JK BioPharma Solutions Inc
Kang Sun Dae
10% Owner
2022-09-23 16:20:230
0
0Form 13D
Shannon Nicola
VP, Clinical Operations
2019-12-30 21:31:010
0
0Form 3